Biotechnology processes are increasingly automated to achieve higher efficiency and consistent product quality. Continuous production, small-scale production, automation and modular production, and digitization are the trend. Due to the fact that the required products are usually only produced by the microorganisms used, it is important to avoid contaminating other organisms. Therefore, new technologies and regulatory requirements will significantly change biotechnology process engineering in the coming years, which is also the direction of research discussed at this meeting.

The meeting opened at 10am and invited keynote speakers——Cong Jianren (East Asia Regional Manager of LABOM Company), for nearly 9 years from 2010 to present, has served as a bridge between the Asian market and the German headquarters, deeply understanding the needs of the pharmaceutical industry in Asia, especially in China, and introducing LABOM Company's targeted products to customers. Florian Simpson, Deputy Sales Director and Overseas Sales Director, was also invited to give a keynote speech on disposable products. The speaker, Cong Jianren, gave a keynote speech on the application of biotechnology.

In his speech, Cong Jianren mentioned that continuous production, small-scale production, automation and modular production, and digitization are currently key trends.

1. Continuous Bioprocessing for continuous production

So far, many products have been produced in batch processing. Continuous process control has many advantages, including smaller batches, such as higher yields and more controllable reaction conditions. For this, comprehensive digitization and good interaction between components are essential.

2. Miniaturization for small-scale production

Miniaturization allows for process control in confined spaces. Due to greater drug personalization, higher product titers, and more effective active ingredients, the reactor volume required for many products is decreasing. In the same analysis, a trend towards miniaturization and high parallelism can be observed, such as in gene sequencing.

3. Automation and modularization: Automated and modular production

Biotechnology processes are increasingly automated to achieve higher efficiency and consistent product quality. Due to the trend towards small batches and greater product diversity, the process flow is designed as modules that can be flexibly interconnected or supplemented.

4. Digitization

Automation, continuous process control, improved process analysis, parallel microreactors, or parallelized analysis systems result in large amounts of data ("big data"). To ensure effective process control and benefit from the collected data, systematic coordination and bioinformatics evaluation of data ("smart data") are required. According to the definition, this term also refers to creating virtual images of the real process.

The wonderful speeches of the two keynote speakers have given colleagues more confidence in the future of biotechnology, and the colleagues present have gained a deeper understanding of the application of bioengineering technology, as well as further knowledge of Labom.

Langbo formulated the company's guidelines 25 years ago, striving to create the most suitable products for the pharmaceutical industry. The company has hired Dr. Christine Scheder for a single position, specializing in researching processes, applications, and prospects in the pharmaceutical industry. The purpose is to support the company's R&D and sales departments in maintaining industry sensitivity and professionalism, in order to better serve our professional clients. Dr. Schweder graduated from the Department of Chemistry at the University of Hanover and obtained his doctoral degree from the Hanover Institute of Technical Chemistry in 2007. Before coming to LABOM, she had been serving as a project manager at the Max Planck Institute for Marine Microbiology in Bremen.

The instruments, meters, and sensor products of German company Langbo are widely used in the biopharmaceutical industry. The control accuracy of Langbo products is in the industry. The advantage of Langbo's pipeline surface temperature measurement products is that they are easy to install and flexible, and can achieve the most hygienic temperature measurement method. In addition, the product can measure temperature on the smallest diameter of 4mm. The advantage of Langbo's online protective tube temperature measurement product is that the protective tube and measuring probe of the product have a special spring structure, which can ensure close contact between the probe and the protective tube, ensuring response speed and measurement accuracy. If calibration or replacement is needed, there is no need to stop the machine. The protective tube can be kept online all the time, and the probe can be directly removed for testing and replacement, which can greatly improve production efficiency. Langbo's differential pressure level gauge has many special technologies, including early calibration and later measurement accuracy control, as well as special LTC diaphragm technology for temperature errors, which can offset 80% or even 90% of temperature drift to ensure that the measurement process and measurement effect are in the best state.

The conference was successfully held with a rigorous and lively atmosphere, allowing participants to understand the forefront of the field, share research results, inspire scientific research ideas, reposition themselves in the industry, and improve their appreciation ability, which is of great significance.